Edmonton - TheNewswire - October 20, 2020. Innovotech Inc. ("Innovotech") (TSXV:IOT) wishes to announce that, in accordance with the policies of the TSX Venture Exchange, the board of directors has approved a grant of stock options to directors and officers of Innovotech to purchase an aggregate of 295,000 common shares pursuant to its stock option plan. These options have an exercise price of $0.21 per common share and expire on October 13, 2025.
About Innovotech Inc.
Innovotech is a Canadian biotechnology company owning proprietary intellectual property, conducting
contract research, and owning and providing proprietary devices for testing in multiple applications in
Director & CFO
This document may contain forward-looking statements that are predictive in nature and subject to risks and
uncertainties that cannot be predicted or quantified; consequently, actual results may differ materially from past
results and those expressed or implied by any forward-looking statements. Factors that could cause or contribute to
such risks or uncertainties include, but are not limited to: the regulatory environment including the difficulty of
predicting regulatory outcomes; changes in the value of the Canadian dollar; the Company's reliance on a small
number of customers including government organizations; fluctuations in operating results; government policies or
actions; progress and cost of clinical trials; reliance on key strategic relationships; uncertainty related to intellectual
property protection and potential costs associated with its defense; the Company's exposure to lawsuits and other
matters beyond the control of management. Should known or unknown risks or uncertainties materialize, or should
management's assumptions prove inaccurate, actual results could vary materially from those anticipated. The
Company undertakes no obligation to publicly make or update any forward-looking statements, except as required
by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy of accuracy of this release.
Copyright (c) 2020 TheNewswire - All rights reserved.